CDR, USPHS
Staff Clinician
Head, Pathogenesis and Therapeutics Section
MD, Uniformed Services University of the Health Sciences
MHS, Duke University School of Medicine
MS, University of Connecticut
Email:
jeffrey.strich@nih.gov
Phone:301-496-9320
CDR, USPHS
Staff Clinician
Head, Pathogenesis and Therapeutics Section
MD, Uniformed Services University of the Health Sciences
MHS, Duke University School of Medicine
MS, University of Connecticut
Email:
jeffrey.strich@nih.gov
Phone:301-496-9320
Dr. Jeffrey R. Strich is a Staff Clinician in the Critical Care Medicine Department at the NIH Clinical Center.
Dr. Strich received his undergraduate degree from the University of Connecticut in Molecular and Cell Biology, his degree in Medicine from the Uniformed Services University of the Health Sciences, and his Masters in Health Services in Clinical Research from the Duke University School of Medicine. He completed residency training in Internal Medicine at Georgetown University Hospital and then completed a combined fellowship in Critical Care Medicine and Infectious Diseases at the National Institutes of Health.
His primary research interests are focused on developing therapies for and understanding the role of the innate immune system in infections that cause critical illness through clinical trials, animal models and ex vivo translational studies with a particular focus on bacterial sepsis and SARS-CoV-2 infection.
Dr. Strich is a Medical Officer in the United States Public Health Services Commissioned Corps. Prior to pursuing his degree in Medicine he served as a Special Assistant in the Office of the Surgeon General.
Dr. Strich is a member of the Infectious Disease Society of America (IDSA) where he serves as the IDSA Sepsis Task Force Executive Secretary, is a member of the Society of Critical Care Medicine and serves on the editorial board of Critical Care Explorations. He holds an appointment as an Adjunct Assistant Professor of Medicine at the Uniformed Services University of the Health Sciences.
Strich JR, Tian X, Samour M, King CS, Shlobin O, Reger, R, Cohen J, Ahmad K, Brown AW, Khangoora V, Shambu A, Migdaddy Y, Kyte JJ, Joo J, Hays R, Collins AC, Battle E, Valdez J, Rivero J, Kim IH, Erb-alvarez J, Shalboub R, Chakrabory M, Wong S, Colton B, Ramos-Benitez MJ, Warner S, Chertow DS, Olivier KN, Aue G, Davey RT, Suffredini AF, Childs RW, Nathan SD. Fostamatinib for the Treatment of Hospitalized Adults with COVID-19: A Randomized Clinical Trial. Clin Infec Dis. 2021. Sept 1.
Strich JR, Ramos-Benitez MJ, Randazzo D, Stein SR, Babyak A, Davey RT, Suffredini AF, Childs RW, Chertow DS. Fostamatinib Inhibits Neutrophil Extracellular Traps Induced by COVID-19 Patient Plasma: A Potential Therapeutic. J Infec Dis. 2021 Mar 29;223(6):981 984.
Kadri SS, Sun J, Lawandi A, Strich JR, Busch LM, Keller M, Babiker A, Yek C, Malik S, Krack J, Dekker JP, Spaulding AB, Ricotta E, Powers JH, Rhee C, Klompas M, Athale J, Boehmer TK, Gundlapalli AV, Bentley W, Datta SD, Danner RL, Demirkale CY, Warner S. Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020. Ann Intern Med. 2021 Sept;174(9):1240-1251
Strich, JR, Ricotta E, Warner S, Demirkale CY, Hohmann SF, Rhee C, Klompas M, Palmore T, Powers JH, Dekker JP, Adjemian J, Matsouaka R, Woods CW, Danner RL, Kadri SS. Pharmacoepidemiology of Ceftazidime-avibactam Use: A Retrospective Cohort Analysis of 210 US Hospitals. Clin Infec Dis. 2021 Feb 16;72(4)611-621.
Strich JR, Heil EL, Masur H. Considerations for Empirical Antimicrobial Therapy in Sepsis and Septic Shock in an Era of Antimicrobial Resistance J Infect Dis. 2020, 21;222: S119-131.
Strich JR, Warner S, Lai YL, Demirkale CY, Powers JH 3rd, Danner RL, Kadri SS. Needs assessment for novel Gram-negative antibiotics in US hospitals: a retrospective cohort study. Lancet Infect Dis. 2020 Jun 4; S1473-3099(20)30153-5.
Strich JR, Warner S, Lai YL, Demirkale C, Powers JH, Danner RL, Kadri, SS. Needs assessment for novel Graam-negative antibiotic in US Hospitals: a retrospective cohort study. Lancet Infect Dis. 2020 May 6.
Strich JR, Ricotta E, Warner S, Demirkale CY, Hohmann SF, Rhee C, Klompas M, Palmore T, Powers JH, Dekker JP, Adjemian J, Matsouaka R, Woods CW, Danner RL, Kadri SS. Pharmacoepidemiology of Ceftazidime-avibactam Use: A Retrospective Cohort Analysis of 210 US Hospitals. Clin Infec Dis. 2020 Feb 28.
Strich JR, Kadri SS. Difficult-to-Treat Antibiotic Resistant Gram-Negative Pathogens in the Intensive Care Unit: Epidemiology, Outcomes, and Treatment. Semin Respir Crit Care Med. 2019 Aug;40(4):419-434.
Strich JR, Wang H, Cisse OH, Youn JH, Drake SK, Chen Y, Rosenberg AZ, Gucek M, McGann PT, Dekker JP, Suffredini AF. Identification of OXA-48 Carbapenemase Family Using Tryptic Peptides and LC-MS/MS. J Clin Microbiol 2019, Feb 27.
Strich JR, Chertow DS. CRISPR-Cas Biology and Infectious Disease Applications. J Clin Microbiol. 2019 Mar 28;57(4)
Kadri SS, Rhee C, Strich JR, Morales M, Hohmann S, Menchaca J, Suffredini A, Danner R, Klompas M. Estimating Ten-Year Trends in Septic Shock Incidence and Mortality in United States Academic Medical Centers Using Clinical Data. Chest. 2017. 151(2):278-285
Visit PubMed.gov for a full list of Dr. Strich's publications.
- NIH Directors Award, 2021
- NHLBI Directors Award, 2021
- USPHS Presidential Unit Citation, 2021
- NIH Clinical Center CEO Award, 2021
- NIH Clinical Center CEO Award, 2020
- USPHS PHS Achievement Medal, 2020
- USPHS Unit commendation, 2020
- USPHS Commendation Medal, 2020
- USPHS Commendation Medal, 2019
- USPHS Unit commendation, 2019
- NIH Clinical Center CEO Award, 2018
- USPHS Presidential Unit Citation, 2016
- Eric Lemmer Memorial Research Award, 2015
- USPHS PHS Achievement Medal, 2013
- USPHS PHS Citation, 2010
- USPHS PHS Citation, 2008
- USPHS PHS Unit Commendation, 2008
- Department of Defense Global War on Terrorism Medal, 2008
- Department of Defense National Defense Service Medal, 2008
NOTE: PDF documents require the free Adobe Reader.
This page last updated on 10/20/2022